May 9, 2025 - 00:12
Penn State Health continues to set the standard for advanced heart care, becoming the first health system in Central Pennsylvania to successfully implant the new Edwards EVOQUE tricuspid valve. This innovative procedure marks a significant milestone in cardiac treatment, offering new hope for patients suffering from tricuspid valve regurgitation.
The EVOQUE valve is designed to provide a less invasive option for patients, allowing for improved recovery times and better overall outcomes. By utilizing advanced technology, the procedure minimizes the risks associated with traditional heart surgeries. The team at Penn State Health, comprised of experienced cardiologists and cardiac surgeons, is dedicated to providing cutting-edge treatments that enhance patient care.
With this pioneering achievement, Penn State Health not only reinforces its commitment to excellence in cardiovascular medicine but also positions itself as a leader in the adoption of new technologies that improve patient quality of life. This advancement is expected to benefit many individuals in the region who require specialized heart care.
